iECURE
  • Home
  • About
    • Our Story
    • Leadership
    • Board of Directors
    • Team
    • Investors
  • Approach
    • In Vivo Gene Insertion
    • Penn Collaboration
  • Programs
    • Overview
    • Pipeline
    • Urea Cycle Disorders
  • Careers
    • Mission
    • Culture
    • Work With Us
  • News
  • Contact
  • Menu Menu

Gene editor may have cured infant of a deadly metabolic disorder

January 30, 2025/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/Science_logo.png 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2025-01-30 17:53:142025-01-30 18:02:36Gene editor may have cured infant of a deadly metabolic disorder

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

January 30, 2025/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/endpoint-news.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2025-01-30 17:45:212025-01-30 17:48:21Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Introducing Fierce Biotech’s 2024 Fierce 15

August 5, 2024/in in the news, news/by David Anderson
https://iecure.com/wp-content/uploads/logo-fiercebiotech.svg 52 280 David Anderson /wp-content/uploads/iEcure_logo.png David Anderson2024-08-05 18:51:242025-01-30 17:48:16Introducing Fierce Biotech’s 2024 Fierce 15

University of Pennsylvania gene-editing spinout iEcure hits the FDA trifecta

May 29, 2024/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/philadelphia-logo.svg 0 0 eallison /wp-content/uploads/iEcure_logo.png eallison2024-05-29 17:19:002024-05-29 17:46:01University of Pennsylvania gene-editing spinout iEcure hits the FDA trifecta

https://endpts.com/fda-greenlights-first-test-of-gene-editing-therapy-in-babies-from-jim-wilson-startup/

April 12, 2024/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/endpoint-news.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2024-04-12 15:36:162024-04-12 15:49:23Exclusive: Jim Wilson startup gets FDA green light for first test of gene editing in babies

https://www.businessinsider.com/list-healthcare-startups-that-will-take-off-in-2022-according-to-investors-2021-11#iecure-14

December 1, 2021/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/insider.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2021-12-01 19:30:422021-12-30 12:41:0634 healthcare and biotech startups that are set to take off in 2022, according to top investors

https://medcitynews.com/2021/09/genetic-meds-pioneer-james-wilson-has-a-new-startup-this-time-in-gene-editing/

December 1, 2021/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/logo-MedCity.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2021-12-01 19:29:522021-12-29 20:44:37Genetic meds pioneer James Wilson has a new startup, this time in gene editing

https://technical.ly/philly/2021/09/10/iecure-gene-editing-series-a/

December 1, 2021/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/logo-tm.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2021-12-01 19:29:062021-12-29 20:47:04Penn gene editing spinout iECURE just raised a $50M Series A

https://cen.acs.org/pharmaceuticals/gene-therapy/Jim-Wilson-launches-liver-disease/99/i33

December 1, 2021/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/cen-logo.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2021-12-01 19:26:302021-12-29 21:00:35Jim Wilson launches liver disease gene-editing company iECURE with $50 million

https://www.fiercebiotech.com/biotech/iecure-emerges-50m-series-a-to-develop-gene-therapies-for-liver-disorders-jim-wilson-s-penn

December 1, 2021/in in the news, news/by eallison
https://iecure.com/wp-content/uploads/logo-fiercebiotech.svg 52 280 eallison /wp-content/uploads/iEcure_logo.png eallison2021-12-01 19:25:272021-12-29 21:02:46iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing
Page 1 of 212
  • Home
  • About
    • Our Story
    • Leadership
    • Board of Directors
    • Team
    • Investors
  • Approach
    • In Vivo Gene Insertion
    • Penn Collaboration
  • Programs
    • Overview
    • Pipeline
    • Urea Cycle Disorders
  • Careers
    • Mission
    • Culture
    • Work With Us
  • News
  • Contact

Copyright 2025 – iECURE | Privacy Notice | Terms of Service | Cookie Notice | Expanded Access Policy

Scroll to top Scroll to top Scroll to top